Abbonarsi

Randomized, Prospective, Comparative Trial of EX-PRESS Glaucoma Filtration Device versus Trabeculectomy (XVT Study) - 15/01/14

Doi : 10.1016/j.ajo.2013.09.014 
Peter A. Netland a, , Steven R. Sarkisian b, Marlene R. Moster c, Iqbal Ike K. Ahmed d, Garry Condon e, Sarwat Salim f, Mark B. Sherwood g, Carla J. Siegfried h
a University of Virginia School of Medicine, Charlottesville, Virginia 
b Dean McGee Eye Institute, University of Oklahoma, Oklahoma City, Oklahoma 
c Wills Eye Hospital, Philadelphia, Pennsylvania 
d University of Toronto, Toronto, Ontario 
e Allegheny General Hospital, Pittsburgh, Pennsylvania 
f Hamilton Eye Institute, University of Tennessee, Memphis, Tennesee 
g University of Florida, Gainesville, Florida 
h Washington University, St. Louis, Missouri 

Inquiries to Peter A. Netland, Department of Ophthalmology, University of Virginia School of Medicine, P.O. Box 800715, Charlottesville, VA 22908-0715

Abstract

Purpose

To compare the clinical outcomes of the EX-PRESS glaucoma filtration device placed under a partial-thickness scleral flap with trabeculectomy.

Design

Randomized, prospective, multicenter trial.

Methods

A total of 120 eyes in 120 subjects were analyzed, including 59 eyes treated with EX-PRESS and 61 eyes treated with trabeculectomy. Both the EX-PRESS and the trabeculectomy groups were treated intraoperatively with mitomycin C and followed postoperatively for 2 years. Surgical success was defined as 5 mm Hg ≤ intraocular pressure ≤ 18 mm Hg, with or without medications, without further glaucoma surgery.

Results

Mean intraocular pressure was significantly reduced compared with baseline in both groups (P < 0.001). Average intraocular pressure and number of medications were similar in both groups during follow-up, with mean intraocular pressure at 2 years after surgery of 14.7 ± 4.6 mm Hg and 14.6 ± 7.1 mm Hg in the EX-PRESS and trabeculectomy groups, respectively (P = 0.927). At 2 years after surgery, the success rate was 83% and 79% in the EX-PRESS and trabeculectomy groups, respectively (P = 0.563). Although visual acuity (logMAR) was significantly decreased on day 1 in both groups, the vision was not significantly different compared with baseline at 1 month after EX-PRESS implant (P = 0.285) and 3 months after trabeculectomy (P = 0.255). The variance of early postoperative intraocular pressure values was similar between groups on the first postoperative day but higher after trabeculectomy compared with EX-PRESS implant on day 7 (P = 0.003). The total number of postoperative complications was higher after trabeculectomy than after EX-PRESS implantation (P = 0.013).

Conclusions

Mean intraocular pressures, medication use, and surgical success were similar at 2 years after treatment with the EX-PRESS device and trabeculectomy. Vision recovery between groups was also similar throughout the study, although return to baseline vision was more rapid in the EX-PRESS group. Intraocular pressure variation was lower during the early postoperative period, and postoperative complications were less common after EX-PRESS implantation compared with trabeculectomy.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Supplemental Material available at AJO.com
 See accompanying Editorial on page 263.


© 2014  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 157 - N° 2

P. 433 - febbraio 2014 Ritorno al numero
Articolo precedente Articolo precedente
  • Impact of Crystalline Lens Opacification on Effective Phacoemulsification Time in Femtosecond Laser-Assisted Cataract Surgery
  • Wolfgang J. Mayer, Oliver K. Klaproth, Fritz H. Hengerer, Thomas Kohnen
| Articolo seguente Articolo seguente
  • Optic Disc Planimetry, Corneal Hysteresis, Central Corneal Thickness, and Intraocular Pressure as Risk Factors for Glaucoma
  • Francis Carbonaro, Pirro G. Hysi, Samantha J. Fahy, Abhishek Nag, Christopher J. Hammond

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.